Tillman Pearce
2012
In 2012, Tillman Pearce earned a total compensation of $1.1M as Chief Medical Officer at Threshold Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $104,508 |
|---|---|
| Option Awards | $705,300 |
| Salary | $306,250 |
| Other | $1,129 |
| Total | $1,117,187 |
Pearce received $705.3K in option awards, accounting for 63% of the total pay in 2012.
Pearce also received $104.5K in non-equity incentive plan, $306.3K in salary and $1.1K in other compensation.
Rankings
In 2012, Tillman Pearce's compensation ranked 5,690th out of 11,487 executives tracked by ExecPay. In other words, Pearce earned more than 50.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,690 out of 11,487 | 51st |
Division Manufacturing | 2,020 out of 4,253 | 53rd |
Major group Chemicals And Allied Products | 495 out of 1,203 | 59th |
Industry group Drugs | 334 out of 925 | 64th |
Industry Pharmaceutical Preparations | 260 out of 700 | 63rd |
Source: SEC filing on April 3, 2015.
Pearce's colleagues
We found six more compensation records of executives who worked with Tillman Pearce at Threshold Pharmaceuticals in 2012.
2012
Harold Selick
Threshold Pharmaceuticals
Chief Executive Officer
2012
Robert Simon
Threshold Pharmaceuticals
Senior Vice President, Regulatory Affairs and Quality Assurance
2012
Joel Fernandes
Threshold Pharmaceuticals
Vice President, Finance & Controller
2012
Stewart Kroll
Threshold Pharmaceuticals
Senior Vice President of Biostatistics and Clinical Operations
2012
Mark Matteucci
Threshold Pharmaceuticals
Senior Vice President, Discovery Research
2012
Nipun Davar
Threshold Pharmaceuticals